HK123694A - (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives - Google Patents

(1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives Download PDF

Info

Publication number: HK123694A
Authority: HK; Hong Kong
Prior art keywords: parts; formula; imidazol; compound; alkyl
Prior art date: 1986-09-15

Application number

HK123694A

Other languages

German (de)

English (en)

French (fr)

Inventor

H. M. Raeymaekers Alfons

J. E. Freyne Eddy

C. Sanz Gerard

Original Assignee

Janssen Pharmaceutica N.V.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-09-15

Filing date

1994-11-10

Publication date

1994-11-18

1994-11-10 Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.

1994-11-18 Publication of HK123694A publication Critical patent/HK123694A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

HK123694A 1986-09-15 1994-11-10 (1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives HK123694A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US90790386A	1986-09-15	1986-09-15

Publications (1)

Publication Number	Publication Date
HK123694A true HK123694A (en)	1994-11-18

Family

ID=25424835

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK123694A HK123694A (en)	1986-09-15	1994-11-10	(1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives

Country Status (23)

Country	Link
EP (1)	EP0260744B1 (ko)
JP (1)	JPS6485975A (ko)
KR (1)	KR960014353B1 (ko)
CN (1)	CN1020903C (ko)
AU (1)	AU595064B2 (ko)
BG (1)	BG61321B2 (ko)
CA (1)	CA1323366C (ko)
CY (1)	CY1803A (ko)
DE (1)	DE3783107T2 (ko)
DK (1)	DK174728B1 (ko)
ES (1)	ES2053524T3 (ko)
FI (1)	FI87781C (ko)
GR (1)	GR3006841T3 (ko)
HK (1)	HK123694A (ko)
HU (1)	HU198039B (ko)
IE (1)	IE60514B1 (ko)
IL (1)	IL83892A (ko)
NO (1)	NO167202C (ko)
NZ (1)	NZ221729A (ko)
PH (1)	PH25022A (ko)
PT (1)	PT85692B (ko)
SU (1)	SU1662350A3 (ko)
ZA (1)	ZA876881B (ko)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826862A (en) *	1988-02-12	1989-05-02	Janssen Pharmaceutica, N.V.	Anthelminthic [(5(6) (1H-azole-1-ylmethyl)benzimidazole]carbamates
GB8827820D0 (en) *	1988-11-29	1988-12-29	Janssen Pharmaceutica Nv	(1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002859C (en) *	1988-11-29	1998-12-29	Jean P. F. Van Wauwe	Method of treating epithelial disorders
CA2002864C (en) *	1988-11-29	1999-11-16	Eddy J. E. Freyne	(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
FR2643903A1 (fr) *	1989-03-03	1990-09-07	Union Pharma Scient Appl	Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
PT95899A (pt) *	1989-11-17	1991-09-13	Glaxo Group Ltd	Processo para a preparacao de derivados indole
US5021448A (en) *	1990-02-22	1991-06-04	Ciba-Geigy Corporation	Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor inhibitor and/or thromboxane receptor antagonist
FR2663028B1 (fr) *	1990-06-08	1994-10-14	Roussel Uclaf	Nouveaux derives de benzimidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5216003A (en) *	1992-01-02	1993-06-01	G. D. Searle & Co.	Diacid-containing benzimidazole compounds for treatment of neurotoxic injury
WO1995004723A1 (fr) *	1993-08-04	1995-02-16	Yamanouchi Pharmaceutical Co., Ltd.	Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive
WO1995009157A1 (en) *	1993-09-30	1995-04-06	Yamanouchi Pharmaceutical Co., Ltd.	Azole derivative and pharmaceutical composition thereof
SG47122A1 (en) *	1994-02-18	1998-03-20	Janssen Pharmaceutica Nv	Enantiomerically pure(-)-liarozole
JPH09508914A (ja) *	1994-02-18	1997-09-09	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	鏡像異性体的に純粋な（＋）−リアロゾール
GB9418443D0 (en) *	1994-09-13	1994-11-02	Pfizer Ltd	Therapeutic agents
US5688810A (en) *	1994-12-22	1997-11-18	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
US6696459B1 (en)	1994-12-22	2004-02-24	Ligand Pharmaceuticals Inc.	Steroid receptor modulator compounds and methods
EP1041066A1 (en) *	1994-12-22	2000-10-04	Ligand Pharmaceuticals Incorporated	Steroid receptor modulator compounds and methods
TW316902B (ko) *	1994-12-28	1997-10-01	Janssen Pharmaceutica Nv
PL322028A1 (en) *	1995-03-01	1998-01-05	Yamanouchi Pharma Co Ltd	Derivatives of imidazoles and pharmaceutic composition containing them
US6288100B1 (en) *	1995-06-06	2001-09-11	American Home Products Corporation	Benzimidazole derivatives
DE19535500A1 (de) *	1995-09-25	1997-03-27	Bayer Ag	Verfahren zur Herstellung von 3-Chlor-3'-nitro-4'-methoxybenzophenon
JP3063162B2 (ja) *	1995-12-28	2000-07-12	藤沢薬品工業株式会社	ベンズイミダゾール誘導体
KR100365312B1 (ko) *	1996-06-27	2003-03-06	얀센 파마슈티카 엔.브이.	N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민
FR2751649B1 (fr) *	1996-07-26	1998-08-28	Adir	Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
IT1286866B1 (it) *	1996-10-28	1998-07-17	Menarini Farma Ind	Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
CN1104422C (zh) *	1996-11-25	2003-04-02	普罗克特和甘保尔公司	用作α－2肾上腺素能受体兴奋剂的胍基杂环化合物
AU6229698A (en)	1997-02-21	1998-09-09	Takeda Chemical Industries Ltd.	Fused ring compounds, process for producing the same and use thereof
TW453999B (en)	1997-06-27	2001-09-11	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
PT1037880E (pt)	1997-12-11	2004-11-30	Janssen Pharmaceutica Nv	Anilidas mimeticas do acido retinoico
DE19831985A1 (de)	1998-07-16	2000-01-20	Bayer Ag	Substituierte Benzimidazole, ihre Herstellung und ihre Verwendung als Mittel gegen parasitäre Protozoen
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
JP2003501418A (ja) *	1999-06-04	2003-01-14	エランファーマインターナショナル，リミティド	細胞死を阻害するための組成物および方法
EP1265853A1 (en)	2000-03-16	2002-12-18	F. Hoffmann-La Roche AG	Carboxylic acid derivatives as ip antagonists
KR100725442B1 (ko)	2000-11-17	2007-06-07	다케다 야쿠힌 고교 가부시키가이샤	신규 이미다졸 유도체, 이의 제조 방법 및 이의 용도
ATE502030T1 (de)	2000-11-20	2011-04-15	Takeda Pharmaceutical	Imidazolderivate, verfahren zu deren herstellung und deren verwendung
CA2431171A1 (en)	2000-12-08	2002-06-13	Takeda Chemical Industries, Ltd.	Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof
US7405235B2 (en)	2001-05-04	2008-07-29	Paratek Pharmaceuticals, Inc.	Transcription factor modulating compounds and methods of use thereof
US6492517B1 (en) *	2001-07-19	2002-12-10	Air Products And Chemicals, Inc.	Method for preparing halomethyl heterocyclic compounds
CN101092400A (zh) *	2001-11-16	2007-12-26	日本化学医药株式会社	黄嘌呤氧化酶抑制剂
WO2004041209A2 (en) *	2002-11-01	2004-05-21	Paratek Pharmaceuticals, Inc.	Transcription factor modulating compounds and methods of use thereof
JP2007500245A (ja) *	2003-06-10	2007-01-11	スミスクラインビーチャムコーポレーション	化合物
FR2860235A1 (fr) *	2003-09-29	2005-04-01	Yang Ji Chemical Company Ltd	Utilisation d'un compose de formule (i) inhibiteur de l'aromatase a des fins therapeutiques et composes de formule (i) en tant que tels
WO2006076009A2 (en)	2004-04-23	2006-07-20	Paratek Pharmaceuticals, Inc.	Transcription factor modulating compounds and methods of use thereof
EP1805147B1 (en) *	2004-09-30	2014-08-13	Janssen Pharmaceutica NV	Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
US7348438B2 (en)	2004-09-30	2008-03-25	Janssen Pharmaceutica N.V.	Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
SI1984343T1 (sl) *	2006-01-24	2013-05-31	Janssen Pharmaceutica N.V.	2-substituirani benzimidazoli kot selektivni modulatorji androgenskih receptorjev (sarms)
EP1987028A2 (en)	2006-02-10	2008-11-05	Transtech Pharma, Inc.	Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
KR101307497B1 (ko) *	2006-04-19	2013-09-11	주식회사 동진쎄미켐	디이미다졸계 화합물 및 이를 이용한 유기발광소자
CN100496308C (zh) *	2006-06-02	2009-06-10	上海烟草（集团）公司	造纸法再造烟叶半逆流多级萃取工艺
EP1992228A1 (en) *	2007-05-14	2008-11-19	Bayer CropScience AG	Insecticidal substituted thiourea derivatives
JP5492075B2 (ja) *	2007-05-23	2014-05-14	アラーガンインコーポレイテッド	アドレナリンレセプター作用薬としての（（二環式ヘテロアリール）イミダゾリル）メチルヘテロアリール化合物
DE102009038950A1 (de)	2009-08-26	2011-03-03	Bayer Animal Health Gmbh	Neue antiparasitäre Kombination von Wirkstoffen
WO2012052540A1 (en) *	2010-10-21	2012-04-26	Universitaet Des Saarlandes	Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
US9199975B2 (en)	2011-09-30	2015-12-01	Asana Biosciences, Llc	Biaryl imidazole derivatives for regulating CYP17
EP2760854B1 (en) *	2011-09-30	2017-08-30	Asana BioSciences, LLC	Imidazole derivatives as cyp17 inhibitors for the treatment of cancer
KR101884447B1 (ko) *	2015-07-06	2018-08-01	삼성에스디아이 주식회사	모노머, 유기막 조성물, 유기막, 및 패턴형성방법
JP2024536342A (ja) *	2021-10-04	2024-10-04	ボルトバイオセラピューティクス、インコーポレーテッド	非対称ビス－ベンゾイミダゾールｓｔｉｎｇアゴニスト免疫複合体及びその使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR75101B (ko) *	1980-10-23	1984-07-13	Pfizer
GB8307865D0 (en) *	1983-03-22	1983-04-27	Fujisawa Pharmaceutical Co	Benzimidazole derivatives
EP0178413A1 (en) *	1984-08-17	1986-04-23	Beecham Group Plc	Benzimidazoles

1987
- 1987-09-08 NZ NZ221729A patent/NZ221729A/xx unknown
- 1987-09-09 CY CY180387A patent/CY1803A/xx unknown
- 1987-09-09 DE DE8787201702T patent/DE3783107T2/de not_active Expired - Lifetime
- 1987-09-09 ES ES87201702T patent/ES2053524T3/es not_active Expired - Lifetime
- 1987-09-09 EP EP87201702A patent/EP0260744B1/en not_active Expired - Lifetime
- 1987-09-14 IE IE248787A patent/IE60514B1/en not_active IP Right Cessation
- 1987-09-14 FI FI873977A patent/FI87781C/fi not_active IP Right Cessation
- 1987-09-14 CA CA000546763A patent/CA1323366C/en not_active Expired - Lifetime
- 1987-09-14 NO NO873840A patent/NO167202C/no unknown
- 1987-09-14 HU HU874071A patent/HU198039B/hu unknown
- 1987-09-14 SU SU874203300A patent/SU1662350A3/ru active
- 1987-09-14 ZA ZA876881A patent/ZA876881B/xx unknown
- 1987-09-14 AU AU78385/87A patent/AU595064B2/en not_active Expired
- 1987-09-14 PH PH35811A patent/PH25022A/en unknown
- 1987-09-14 PT PT85692A patent/PT85692B/pt unknown
- 1987-09-14 JP JP62228679A patent/JPS6485975A/ja active Granted
- 1987-09-14 DK DK198704794A patent/DK174728B1/da not_active IP Right Cessation
- 1987-09-14 IL IL83892A patent/IL83892A/xx not_active IP Right Cessation
- 1987-09-15 CN CN87106423A patent/CN1020903C/zh not_active Expired - Lifetime
- 1987-09-15 KR KR1019870010180A patent/KR960014353B1/ko not_active Expired - Lifetime
1993
- 1993-01-21 GR GR930400092T patent/GR3006841T3/el unknown
- 1993-07-15 BG BG097951A patent/BG61321B2/bg unknown
1994
- 1994-11-10 HK HK123694A patent/HK123694A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI87781B (fi)	1992-11-13
FI87781C (fi)	1993-02-25
NZ221729A (en)	1989-07-27
DK479487D0 (da)	1987-09-14
EP0260744A2 (en)	1988-03-23
AU7838587A (en)	1988-04-14
IE60514B1 (en)	1994-07-27
SU1662350A3 (ru)	1991-07-07
DE3783107D1 (de)	1993-01-28
NO873840L (no)	1988-03-16
FI873977A0 (fi)	1987-09-14
IL83892A (en)	1991-11-21
IE872487L (en)	1988-03-15
CA1323366C (en)	1993-10-19
DK479487A (da)	1988-03-16
CN1020903C (zh)	1993-05-26
PT85692B (pt)	1990-06-29
JPH0587071B2 (ko)	1993-12-15
ZA876881B (en)	1989-04-26
GR3006841T3 (ko)	1993-06-30
KR960014353B1 (ko)	1996-10-15
CN87106423A (zh)	1988-04-20
HUT45051A (en)	1988-05-30
DE3783107T2 (de)	1993-04-22
NO167202B (no)	1991-07-08
CY1803A (en)	1987-09-09
IL83892A0 (en)	1988-02-29
ES2053524T3 (es)	1994-08-01
DK174728B1 (da)	2003-10-06
HU198039B (en)	1989-07-28
PH25022A (en)	1991-01-28
FI873977A7 (fi)	1988-03-16
NO167202C (no)	1991-10-16
JPS6485975A (en)	1989-03-30
PT85692A (en)	1987-10-01
NO873840D0 (no)	1987-09-14
EP0260744B1 (en)	1992-12-16
BG61321B2 (bg)	1997-05-30
EP0260744A3 (en)	1989-01-18
KR880003935A (ko)	1988-06-01
AU595064B2 (en)	1990-03-22

Publication	Publication Date	Title
EP0260744B1 (en)	1992-12-16	(1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives
US4859684A (en)	1989-08-22	(1H-imidazol-1-ylmethyl) substituted benzimidazole derivatives and use thereof in treating androgen dependent disorders
EP0293978B1 (en)	1993-09-15	(1h-azol-1-ylmethyl)substituted benzotriazole derivatives
US4931444A (en)	1990-06-05	5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
EP0371564A2 (en)	1990-06-06	(1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives
US5037829A (en)	1991-08-06	(1H-azol-1-ylmethyl) substituted quinazoline derivatives
US5151421A (en)	1992-09-29	(1h-azol-1-ylmethyl) substituted quinoxaline derivatives
HK46295A (en)	1995-04-07	Novel derivatives of [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1h-imidazoles and 1h-1,2,4-triazoles
US4943574A (en)	1990-07-24	(1H-azol-1-ylmethyl) substituted benzotriazole derivatives and pharmaceutical compositions containing them
PH27056A (en)	1993-02-01	Ú5(6) (1H-azole-1-ylmethyl) benzimidazole
EP0426225A2 (en)	1991-05-08	(6,7-dihydro-5H-pyrrolo[1,2-c]-imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
US5066656A (en)	1991-11-19	Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
KR960015004B1 (ko)	1996-10-23	(1h-이미다졸-1-일메틸)치환된 벤즈이미다졸 유도체의 제조방법
US5039677A (en)	1991-08-13	6-(1H-azol-1-ylmethyl)-1-(pyrimidinyloxy)-1H benzotriazoles
US5441954A (en)	1995-08-15	(1h-azol-1-ylmethyl) substituted quinoline derivatives
PH26050A (en)	1992-01-29	(1H-azol-1=ylmethyl)substituted benzotriazole derivatives

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2007-10-12	PE	Patent expired	Effective date: 20070908